These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 29544122)

  • 1. [
    Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
    Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Amor-Coarasa A; Kelly JM; Singh PK; Ponnala S; Nikolopoulou A; Williams C; Vedvyas Y; Jin MM; Warren JD; Babich JW
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31022852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Contrast CXCR4-Targeted
    Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
    Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of
    Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S
    Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of CXCR4 expression using [
    Cheng K; Wang S; Liu T; Pei J; Wang S; Liu J; Zhao K; Luo Y; Xu S; Yu J; Liu J
    Theranostics; 2024; 14(16):6337-6349. PubMed ID: 39431004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-step
    Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J
    Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
    Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
    Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
    Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation Al
    Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F
    Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
    Mou T; Zhao Z; You L; Wang Q; Fang W; Lu J; Peng C; Zhang X
    J Labelled Comp Radiopharm; 2015 Jun; 58(8):349-54. PubMed ID: 26094722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
    Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
    Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.